Associated Papers
A Study of Nuclear Factor-Kappa B1 Gene Polymorphism Types in Schizophrenia Patients and Their Correlation With Disease Severity.
Swain SA et al.
Cureus, 2022
NF-κB1 promoter-94ins/delATTG polymorphisms correlate with the acute exacerbation of chronic obstructive pulmonary disease.
Meng X et al.
Journal of Thoracic Disease, 2019
NFKB1 gene rs28362491 polymorphism is associated with the susceptibility of acute coronary syndrome.
Jin SY et al.
Bioscience Reports, 2019
NFKB1 promoter polymorphism: A new predictive marker of cytomegalovirus infection after kidney transplantation.
Leone F et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society, 2019
Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.
Fliegauf M et al.
American Journal of Human Genetics, 2015
Functional polymorphisms in NFκB1/IκBα predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese.
Huang D et al.
Human Genetics, 2013
Roles of functional NFKB1 and β-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility.
Huo ZH et al.
Genetics and Molecular Research : Gmr, 2013
Interleukin-10 gene promoter and NFKB1 promoter insertion/deletion polymorphisms in systemic sclerosis.
Salim PH et al.
Scandinavian Journal of Immunology, 2013
Genome-wide association study of treatment refractory schizophrenia in Han Chinese.
Liou YJ et al.
Plos One, 2012
NFKB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population.
Fan Y et al.
Dna and Cell Biology, 2011
NFKB1-94ins/del polymorphism is not associated with lung injury after cardiopulmonary bypass.
Wang JF et al.
Anaesthesia, 2010
No association of the NFKB1 insertion/deletion promoter polymorphism with survival in patients with gastric cancer.
Kim JG et al.
Japanese Journal of Clinical Oncology, 2009
Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients.
Lo SS et al.
Surgery, 2009
The functional role of nuclear factor kappa-kappaB1 -94 ins/del ATTG promotor gene polymorphism in Behçet's disease: an exploratory study.
Yalcin B et al.
Clinical and Experimental Dermatology, 2008
Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients.
Bu H et al.
Journal of Cancer Research and Clinical Oncology, 2007
No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia.
Riemann K et al.
Pharmacogenetics and Genomics, 2006
Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes.
Glas J et al.
Inflammatory Bowel Diseases, 2006
Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis.
Karban AS et al.
Human Molecular Genetics, 2004
No association of the NF-kappaB1 -94ins/delATTG promoter polymorphism with relapse-free and overall survival in patients with squamous cell carcinomas of the head and neck region.
Lehnerdt GF et al.
International Journal of Immunopathology and Pharmacology, 0